<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03465358</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL17_0851</org_study_id>
    <nct_id>NCT03465358</nct_id>
  </id_info>
  <brief_title>Validation of Completion of Items 18, 19 and 22 of the Motor Function Measure (MFM) on a Digital Tablet</brief_title>
  <acronym>MFM-tablet</acronym>
  <official_title>Validation of Completion of Items 18, 19 and 22 of the Motor Function Measure (MFM) on a Digital Tablet</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Motor Function Measure (MFM) is a validated tool assessing the motor function of
      neuromuscular patients constituted of 32 items. Despite standardized Motor Function Measure
      (MFM) training sessions, there is still an inter-individual variability in the items' scoring
      procedure, depending for example on the subjectivity of the therapist.

      Among the 32 items of the MFM, 3 currently require the use of a paper, and could be automated
      by using a digital tablet. It is the item 18 where the patient traces the edge of a Compact
      Disc, item 19 requiring to draw loops inside a frame and item 22 requiring to place a finger
      on each standardized cases. The reproducibility of these 3 items could be improved with the
      use of a digital tablet and the development of a software allowing to computerize the scoring
      procedure. The second interest is to implement directly the MFM data in the MFM base.

      The hypothesis is that the difference of scoring of these 3 items between digital tablet
      versus paper completion is enough low to use indifferently each completion in patients with a
      neuromuscular disease.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2018</start_date>
  <completion_date type="Anticipated">July 2019</completion_date>
  <primary_completion_date type="Anticipated">April 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison scoring between items completed using conventional material or on a digital tablet.</measure>
    <time_frame>1 day</time_frame>
    <description>The comparison of scores between usual test (paper) versus digital tablet test, for the item 18, 19 and 22 of the Motor Function Measure.</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Neuromuscular Diseases</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Items completion</intervention_name>
    <description>Patients will complete his Motor Function Measure in the usual way, except items 18, 19 and 22 which will be completed twice: once using conventional material and once on a digital tablet.
The order of completion between conventional material or digital tablet will be allocate randomly.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with neuromuscular disease
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with a labelled neuromuscular disease

          -  Patients with Motor Function Measure in one of the participating services during their
             usual follow-up

          -  Patients who received the information and did not object to participating in the study
             or their parents for the children

        Exclusion Criteria:

          -  Patients passing their Motor Function Measure as part of another research protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Carole VUILLEROT, Dr</last_name>
    <phone>04.72.12.95.04</phone>
    <phone_ext>+33</phone_ext>
    <email>carole.vuillerot@chu-lyon.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dominique VINCENT-GENOD</last_name>
    <phone>04.72.12.95.04</phone>
    <phone_ext>+33</phone_ext>
    <email>dominique.vincent-genod@chu-lyon.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service de Rééducation Fonctionnelle Pédiatrique - L'Escale (Aile A1) - Hôpital Femme Mère Enfant - GHE</name>
      <address>
        <city>Bron</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Carole VUILLEROT, Dr</last_name>
      <phone>04.72.12.95.04</phone>
      <phone_ext>+33</phone_ext>
      <email>carole.vuillerot@chu-lyon.fr</email>
    </contact>
    <contact_backup>
      <last_name>Dominique VINCENT-GENOD</last_name>
      <phone>04.72.12.95.04</phone>
      <phone_ext>+33</phone_ext>
      <email>dominique.vincent-genod@chu-lyon.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Carole VUILLEROT, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre de référence MNM Adulte Grenoble Consultation Maladies Neuromusculaires Adultes - CHU Michallon</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Emeline LAGRANGE, Dr</last_name>
      <phone>04 76 76 61 61</phone>
      <phone_ext>+33</phone_ext>
      <email>ELagrange@chu-grenoble.fr</email>
    </contact>
    <investigator>
      <last_name>Emeline LAGRANGE, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre de référence MNM adulte Lyon Hôpital de la Croix Rousse Bâtiment P</name>
      <address>
        <city>Lyon</city>
        <zip>69317</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Capucine DE LATTRE, Dr</last_name>
      <phone>04 72 07 25 73</phone>
      <phone_ext>+33</phone_ext>
      <email>capucine.de-lattre@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Capucine DE LATTRE, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre de référence MNM Adulte Saint Etienne CHU Hôpital Nord-service neurologie</name>
      <address>
        <city>Saint-Priest-en-Jarez</city>
        <zip>42270</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Léonard FEASSON, Pr</last_name>
      <phone>04 77 12 04 24</phone>
      <phone_ext>+33</phone_ext>
      <email>leonard.feasson@chu-st-etienne.fr</email>
    </contact>
    <investigator>
      <last_name>Léonard FEASSON, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de Médecine Physique et de Réadaptation Pédiatrique Hôpital de Bellevue, CHU</name>
      <address>
        <city>Saint-Étienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vincent GAUTHERON, Pr</last_name>
      <phone>04 77 82 87 29</phone>
      <phone_ext>+33</phone_ext>
      <email>vincent.gautheron@chu-st-etienne.fr</email>
    </contact>
    <investigator>
      <last_name>Vincent GAUTHERON, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 8, 2018</study_first_submitted>
  <study_first_submitted_qc>March 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 14, 2018</study_first_posted>
  <last_update_submitted>March 8, 2018</last_update_submitted>
  <last_update_submitted_qc>March 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuromuscular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

